| __timestamp | Halozyme Therapeutics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 22732000 | 117418000 |
| Thursday, January 1, 2015 | 29245000 | 102526000 |
| Friday, January 1, 2016 | 33206000 | 105386000 |
| Sunday, January 1, 2017 | 31152000 | 110188000 |
| Monday, January 1, 2018 | 10136000 | 121544000 |
| Tuesday, January 1, 2019 | 45546000 | 127930000 |
| Wednesday, January 1, 2020 | 43367000 | 148917000 |
| Friday, January 1, 2021 | 81413000 | 440760000 |
| Saturday, January 1, 2022 | 139304000 | 540517000 |
| Sunday, January 1, 2023 | 192361000 | 435577000 |
| Monday, January 1, 2024 | 159417000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding cost structures is pivotal. Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc. have shown intriguing trends in their cost of revenue from 2014 to 2023. Jazz Pharmaceuticals, with a consistent upward trajectory, peaked in 2022, marking a 360% increase from 2014. Meanwhile, Halozyme Therapeutics exhibited a remarkable surge, especially from 2020 onwards, culminating in a 740% rise by 2023. This stark contrast highlights Jazz's steady growth strategy versus Halozyme's aggressive expansion. The data underscores the importance of strategic cost management in the pharmaceutical sector, where every dollar spent can significantly impact innovation and market positioning. As these companies navigate the complexities of healthcare demands, their financial strategies offer valuable insights into sustaining growth and competitiveness.
Novo Nordisk A/S vs Halozyme Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Alkermes plc
Jazz Pharmaceuticals plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Halozyme Therapeutics, Inc. and Pharming Group N.V.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Mesoblast Limited's Expenses
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.